Liver Findings in Patients with Hereditary Hemorrhagic Telangiectasia
نویسندگان
چکیده
منابع مشابه
liver findings in patients with hereditary hemorrhagic telangiectasia
conclusion the involved liver with hht typically shows vascular shunting and biliary diseases. also, arteriovenous shunts may be vulnerable to biliary diseases. results (i) three types of shunting were found in the livers, including arteriovenous (hepatic artery to hepatic vein) in 6 cases, arterioportal (hepatic artery to portal vein) in 2 cases, and portal venous (portal vein to hepatic vein)...
متن کاملLiver Findings in Patients with Hereditary Hemorrhagic Telangiectasia
BACKGROUND Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is a rare autosomal dominant genetic vascular dysplasia. OBJECTIVES The aim is to characterize the liver involvement of HHT by multi-detector helical computed tomography. PATIENTS AND METHODS Through the use of multi-detector helical computed tomography, scan data derived from 12 cases of HHT w...
متن کاملContact endoscopic findings in hereditary hemorrhagic telangiectasia.
BACKGROUND Hereditary hemorrhagic telangiectasia is characterized by angiodysplastic lesions. So far, knowledge is limited on the vascular architecture and rate of occult manifestation of telangiectases. Contact endoscopy has not been used for this task before. METHODS Eleven patients with hereditary hemorrhagic telangiectasia were examined with contact endoscopy to identify occult telangiect...
متن کاملHereditary hemorrhagic telangiectasia/avastin.
This is the first scientific report of hereditary hemorrhagic telangiectasia (HHT) epistaxis treatment by intranasal spraying of the vascular endothelial growth factor (VEGF) inhibitor bevacizumab (Avastin). Epistaxis in patients with HHT is a morbid, mortal condition that is difficult and unpleasant to manage. Nasal telangiectasia growth is modulated by VEGF, which is elevated in HHT patients....
متن کاملHereditary Hemorrhagic Telangiectasia Management.
Hereditary hemorrhagic telangiectasia (HHT) is an inherited disorder that can lead to frequent and severe sequelae. Although the condition has no cure, many of its physical symptoms can be managed to improve the quality of life and lower the risk of life-threatening complications. This article discusses HHT presentation, genetic screening, diagnosis, and management. The management of HHT can in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Iranian Journal of Radiology
سال: 2016
ISSN: 1735-1065,2008-2711
DOI: 10.5812/iranjradiol.31116